Inorganic arsenic (iAs) is an environmental toxicant currently poisoning millions of people worldwide, and chronically exposed individuals are susceptible to arsenicosis or arsenic poisoning. Using a state-of-the-art technique to map the methylomes of our study subjects, we identified a large interactome of hypermethylated genes that are enriched for their involvement in arsenic-associated diseases, such as cancer, heart disease, and diabetes. Notably, we have uncovered an arsenic-induced tumor suppressorome, a complex of 17 tumor suppressors known to be silenced in human cancers. This finding represents a pivotal clue in unraveling a possible epigenetic mode of arsenic-induced disease
Background: It has been hypothesized that inorganic arsenic (iAs), an important environmental carci...
Chronic exposures to arsenic and estrogen are known risk factors for prostate cancer. Though the evi...
Background Exposure to inorganic arsenic increases the risk of cancer and non-malignant diseases. In...
Inorganic arsenic (iAs) is an environmental toxicant currently poisoning millions of people worldwid...
BackgroundExposure to arsenic, an established human carcinogen, through consumption of highly contam...
Worldwide chronic arsenic (As) poisoning by arsenic-contaminated groundwater is one of the most thre...
Arsenic is an established human carcinogen, but the mechanisms through which it contributes to for i...
Arsenic is a crucial environmental metalloid whose high toxicity levels negatively impact human heal...
BACKGROUND: Arsenic exposure affects [Formula: see text] people worldwide, including [Formula: see t...
BackgroundChronic exposure to arsenic (As), a human toxicant and carcinogen, remains a global public...
Arsenic is a known human carcinogen,1 although it’s unclear how it causes cancer. Some studies have ...
Biotransformation of inorganic arsenic (iAs) is one of the factors that determines the character and...
Arsenic is carcinogenic, possibly partly through epigenetic mechanisms. We evaluated the effects of ...
The mechanisms by which arsenic-induced genomic instability is initiated and maintained are poorly u...
Introduction There is a need to identify processes underlying development of chemically induced chr...
Background: It has been hypothesized that inorganic arsenic (iAs), an important environmental carci...
Chronic exposures to arsenic and estrogen are known risk factors for prostate cancer. Though the evi...
Background Exposure to inorganic arsenic increases the risk of cancer and non-malignant diseases. In...
Inorganic arsenic (iAs) is an environmental toxicant currently poisoning millions of people worldwid...
BackgroundExposure to arsenic, an established human carcinogen, through consumption of highly contam...
Worldwide chronic arsenic (As) poisoning by arsenic-contaminated groundwater is one of the most thre...
Arsenic is an established human carcinogen, but the mechanisms through which it contributes to for i...
Arsenic is a crucial environmental metalloid whose high toxicity levels negatively impact human heal...
BACKGROUND: Arsenic exposure affects [Formula: see text] people worldwide, including [Formula: see t...
BackgroundChronic exposure to arsenic (As), a human toxicant and carcinogen, remains a global public...
Arsenic is a known human carcinogen,1 although it’s unclear how it causes cancer. Some studies have ...
Biotransformation of inorganic arsenic (iAs) is one of the factors that determines the character and...
Arsenic is carcinogenic, possibly partly through epigenetic mechanisms. We evaluated the effects of ...
The mechanisms by which arsenic-induced genomic instability is initiated and maintained are poorly u...
Introduction There is a need to identify processes underlying development of chemically induced chr...
Background: It has been hypothesized that inorganic arsenic (iAs), an important environmental carci...
Chronic exposures to arsenic and estrogen are known risk factors for prostate cancer. Though the evi...
Background Exposure to inorganic arsenic increases the risk of cancer and non-malignant diseases. In...